Agnese Martina

Sales PM & Strategic Projects Manager at Biofarma Group

Agnese Martina is an experienced professional in procurement and project management, currently serving as Sales PM & Strategic Projects Manager at Biofarma Group since May 2021, previously holding the role of Strategic Projects Coordinator. Prior experience includes serving as Senior Buyer Services at Acciaierie Bertoli Safau SpA from September 2018 to April 2021, and as Strategic Buyer at Bob Martin from January 2016 to December 2017, where coordination of the procurement team and Asian sourcing for pet accessories were key responsibilities. Agnese's earlier work at Nestlé Purina Pet Care spanned from 2005 to 2015, where roles included Strategic Buyer and End to End Project Manager, overseeing various European innovation projects. Early career highlights include positions as Junior Buyer at Misa and in the Export Department at Nestlé Purina PetCare in Europe, the Middle East, and North Africa. Agnese holds a degree from Università degli Studi di Udine and has furthered education at the University of Galway.

Links

Previous companies


Org chart

No direct reports

Teams

This person is not in any teams


Offices

This person is not in any offices


Biofarma Group

1 followers

Biofarma Group is the global player that develops, produces and packages food supplements, medical devices, probiotic-based drugs and cosmetics, exclusively for third parties. Including 4 production sites in Italy (Friuli Venezia Giulia - HQ, Veneto and Lombardy), 2 production sites in France, 1 in the USA and 1 in China, Biofarma Group offers customized solutions and a comprehensive service, from the development of the idea to the finished product. The Company offers to customers a broad catalogue of products ready for distribution, some of them with clinical studies, and medical devices available in out-licensing including dossiers, some of them patented, with the possibility of being marketed all over the world. Innovation, competence and excellence are the values that, combined with investments in production processes, cutting-edge machinery and human capital, allow the Group to represent, globally, a highly attractive and competitive landmark in the development and manufacture of Health-Care and Beauty Care products.